The scientist behind the first potential Covid-19 vaccine to clear interim clinical trials and has been found to be 90 per cent effective said that “if everything continues to go well…we could have a normal winter next year.
BioNTech co-founder UgurSahintold BBC One’s The Andrew Marr Show on Sunday: “this winter will be hard and the vaccine will not have a big impact on the infection numbers. But he said that if everything continues to go well, the goal is to deliver more than 300 million doses of the vaccine before April next year, which could allow us to already start